Suchergebnisse - "Sirkisoon, Sherona"

PubPharm (6)

1

NEDD4 degrades TUSC2 to promote glioblastoma progression

enthalten in: Cancer letters | 2022

von Rimkus, T. | Arrigo, A. | Zhu, D. | +13

2

Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis

enthalten in: Oncogene | 2020

von Doheny, D. | Sirkisoon, S. | Carpenter, R. | +15

3

TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment

enthalten in: Oncogene | 2020

von Sirkisoon, S. | Carpenter, R. | Rimkus, T. | +16

ErratumIn: Oncogene. 2021 Mar;40(12):2338. - PMID 33654200

4

Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer

enthalten in: Oncogene | 2018

von Sirkisoon, S. | Carpenter, R. | Rimkus, T. | +6

5

Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44

enthalten in: Cancer research | 2018

von Rimkus, T. | Carpenter, R. | Sirkisoon, S. | +8

6

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers

enthalten in: Discovery medicine | 2017

von Rimkus, T. | Sirkisoon, S. | Harrison, A. | +1

1
[1]